Avalere Essential Voice
95 episodes - English - Latest episode: over 1 year ago -Twenty years ago, Avalere set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to listen to our experts discuss the hot topics that you need to track.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
RSV Prevention, Part IV: Immunocompromised Populations
October 31, 2022 18:30 - 12 minutes - 17 MBTune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.
RSV Prevention, Part III: Older Adult Vaccination
October 19, 2022 18:07 - 13 minutes - 17.9 MBTune into the third episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the future of RSV among older adults.
RSV Prevention, Part II: Pediatric Vaccines and Maternal immunization
October 05, 2022 18:56 - 9 minutes - 13.2 MBTune into the second episode in our miniseries focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss RSV prevention products currently in development, specifically maternal immunizations and pediatric vaccines.
RSV Prevention, Part I: Pediatric Monoclonal Antibodies
September 28, 2022 19:16 - 8 minutes - 12 MBTune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.
NCDs, Part III: Agency Mandates, Decisions, Coverage, and Access
September 14, 2022 19:01 - 9 minutes - 13.6 MBTune into the third episode in the Avalere Health Essential Voice podcast series focused on Agency decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs) by considering how potential policy and market catalysts 3 to 5 years out may help stakeholders think through opportunities and risks at key decision points ranging from early in development to implications for Part D.
NCDs, Part II: Evidence Development to Fulfill CED Requirements
June 22, 2022 18:07 - 20 minutes - 28.8 MBTune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS’s evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclon...
NCDs, Part I: Overview of NCDs, CED, and Potential Access Barriers
June 16, 2022 15:47 - 13 minutes - 18.5 MBTune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.
Exploring the Kidney Care Environment, Part III: Addressing Healthcare Disparities
March 28, 2022 14:29 - 10 minutes - 14.5 MBIn the third and final episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share insights on disparities in kidney care. Listen to previous episodes in this series: Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems Exploring the Kidney Care Environment, Part II, Policy and Payment Trends
Exploring the Kidney Care Environment, Part II: Policy and Payment Trends
March 10, 2022 21:38 - 10 minutes - 13.7 MBIn the second episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share their perspective on policy and payment trends. Listen to previous episodes in this series: Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems
Intro to the Kidney Care Environment: Key Players, Treatment, and Payment Systems
March 03, 2022 17:15 - 7 minutes - 10.3 MBIn this episode of Avalere Health Essential Voice, we kick off our miniseries focused on the evolving kidney care landscape.
HIV/AIDS Prevention and Treatment, Part II
December 09, 2021 21:37 - 33 minutes - 45.4 MBIn this episode of the Avalere Health Essential Voice, we welcome leaders from the National Alliance of State & Territorial AIDS Directors (NASTAD) to discuss state HIV policies and barriers to ending the HIV epidemic in the US.
World AIDS Day: HIV/AIDS Prevention and Treatment
December 01, 2021 17:46 - 18 minutes - 25.2 MBIn this episode of the Avalere Health Essential Voice, we welcome Carl Schmid, Executive Director at the HIV + Hepatitis Policy Institute, to commemorate World AIDS Day on December 1.
Navigating Distribution and Third-Party Logistics, Part III
November 30, 2021 19:13 - 22 minutes - 30.3 MBIn this episode of Avalere Health Essential Voice, our experts continue their discussion on channel strategy development for bringing a drug to market. Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i Tune into Part 2 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-ii
Navigating Distribution and Third-Party Logistics, Part II
November 16, 2021 17:02 - 19 minutes - 27 MBIn this episode of Avalere Health Essential Voice, our experts welcome leaders from Gilead Sciences and Jazz Pharmaceuticals to discuss channel distribution strategy. Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
Medicare Part D, Part V: What's Next for CMMI?
October 22, 2021 16:03 - 9 minutes - 12.8 MBIn this episode of Avalere Health Essential Voice, the fifth and final in our Medicare Part D miniseries, our experts discuss the Center for Medicare & Medicaid Innovation (CMMI) and where we can anticipate some activity in the coming year, particularly as it relates to the Part D program.
Medicare Part D, Part IV: Budget Neutrality and Congressional Scoring
October 15, 2021 16:15 - 12 minutes - 16.6 MBIn this episode of Avalere Health Essential Voice, the fourth in our Medicare Part D miniseries, our experts discuss key elements of the legislative process including budget neutrality and congressional scoring.
Medicare Part D, Part III: Impact of Policy Changes on Market Access
October 07, 2021 14:58 - 8 minutes - 11.4 MBIn this episode of Avalere Health Essential Voice, the third in our Medicare Part D miniseries, our experts discuss policy changes and the impact on market access.
Medicare Part D, Part II: Understanding Plan Decision-Making
September 30, 2021 14:27 - 14 minutes - 19.8 MBIn this episode of Avalere Health Essential Voice, the second in our Medicare Part D miniseries, our experts discuss how health plans make decisions within Part D.
Cell and Gene Therapy in Oncology, Part III
September 29, 2021 14:31 - 11 minutes - 16.1 MBIn this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the need for patient support in cell and gene therapies and the ways in which various stakeholders provide it.
Medicare Part D, Part I: Key Trends and Pressures
September 23, 2021 20:19 - 12 minutes - 16.7 MBIn this episode of Avalere Health Essential Voice, the first in our Medicare Part D miniseries, our experts discuss Part D trends and pressures in the evolving drug pricing environment.
What's Next for Health Policy on Capitol Hill?
September 14, 2021 17:17 - 17 minutes - 24.7 MBIn this episode of Avalere Health Essential Voice, our experts discuss what they expect to see from a legislative perspective this fall on Capitol Hill.
The Coverage Gap and Medicaid Expansion
September 10, 2021 20:42 - 14 minutes - 19.6 MBIn this episode of Avalere Health Essential Voice, our experts discuss the forthcoming debate around the coverage gap for individuals residing in states that have not participated in Medicaid expansion.
Navigating Distribution and Third-Party Logistics , Part I
September 02, 2021 12:00 - 36 minutes - 49.6 MBIn this episode of Avalere Health Essential Voice, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the use of third-party logistics companies for distribution, warehousing, and fulfillment in biopharma.
Cell and Gene Therapy in Oncology, Part II
June 29, 2021 16:44 - 10 minutes - 14.9 MBIn this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.
Huntington’s Disease: Challenges and Treatment
May 25, 2021 18:25 - 7 minutes - 10.6 MBIn this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss Huntington’s Disease through the lens of its symptoms, challenges, and potential treatment.
Direct Contracting and Advancing Home-Based Care with Landmark Health
May 06, 2021 19:05 - 23 minutes - 32.7 MBIn this episode of Start Your Day with Avalere, Chris Johnson of Landmark Health joins us to discuss his organization’s experience as an early participant in CMMI’s Direct Contracting payment model.
Cell and Gene Therapy in Oncology, Part I
May 05, 2021 20:36 - 11 minutes - 16.3 MBIn this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the challenges surrounding cell and gene therapies from both the patient and payer perspective.
Impacts of the Affordable Care Act's Medicaid Expansion on Women of Reproductive Age: Differences by Parental Status and State Policies
April 30, 2021 15:55 - 14 minutes - 19.7 MBIn this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a study on the impact of Medicaid expansion on coverage and care for women of reproductive age.
Infusing the Patient Perspective into Value Assessment, Part III
April 15, 2021 19:57 - 13 minutes - 19 MBIn this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the final session in our 3-part series on infusing the patient perspective into value assessment.
COVID-19 and Oncology Care
April 09, 2021 14:00 - 15 minutes - 21.3 MBIn this episode of the Avalere Health Essential Voice Disease Education Series, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the state of oncology care from a provider and a patient perspective as we continue to look at the impact of COVID-19 and prepare for post-pandemic realities.
Healthcare Price Transparency
April 06, 2021 21:11 - 25 minutes - 34.6 MBIn this episode of Start Your Day with Avalere, our policy experts discuss healthcare price transparency efforts and the anticipated impact of making previously confidential pricing information public.
Infusing the Patient Perspective Into Value Assessment, Part II
March 25, 2021 21:22 - 10 minutes - 13.9 MBIn this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the second of a three-part series on infusing the patient perspective into value assessment.
Oncology Care and NCCN Key Takeaways
March 25, 2021 17:47 - 29 minutes - 39.9 MBIn this episode of Avalere Health Essential Voice, experts from our Market Access practice discuss major takeaways from the 2021 National Comprehensive Cancer Network annual conference.
Infusing the Patient Perspective Into Value Assessment, Part I
March 22, 2021 20:26 - 18 minutes - 25.9 MBIn this episode of the Avalere Health Essential Voice Start Your Day with Avalere series, our experts kick off a three-part series on incorporating the patient perspective in value assessment.
Malnutrition and Quality Improvement
March 22, 2021 15:58 - 14 minutes - 19.9 MBIn this episode of our Avalere Health Essential Voice Disease Education series, experts from our Center for Healthcare Transformation discuss the prevalence of malnutrition, its impact on the healthcare system, and the Avalere-led quality improvement initiative created to address it.
Understanding Shifting Insurance Coverage Impacts
March 19, 2021 12:30 - 58 minutes - 80.4 MBTune in to the replay of our webinar, Understanding Shifting Insurance Coverage Impacts to hear Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers. As a result of the COVID-19 pandemic and associated economic downturn, millions of Americans have lost employer-sponsored insurance and have either enrolled in publicly subsidized coverage or become uninsured....
Senior Health and Well-Being During COVID-19
March 10, 2021 18:59 - 16 minutes - 22.3 MBIn this episode of Avalere Health Essential Voice, President and CEO of Tivity Health, Richard Ashworth, joins us to discuss the impact of COVID-19 on seniors’ health and wellbeing, and how this population’s attitude toward the COVID vaccine continues to evolve.
Strong Start in Birth Centers: Socio‐Demographic Characteristics, Care Processes, and Outcomes for Mothers and Newborns
March 08, 2021 20:59 - 11 minutes - 15.8 MBIn this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent analysis of birth centers as an enhanced, evidence-based care model in CMS’s Strong Start initiative.
COVID-19: Lessons Learned and the Path Forward
March 03, 2021 17:51 - 1 hour - 82.6 MBTune in to the replay of our webinar, COVID-19: Lessons Learned and the Path Forward to hear Avalere’s panel of policy, public health, and regulatory experts discuss the challenges, opportunities, and key milestones to watch. As we near the 1-year COVID-19 pandemic declaration, new issues and questions emerge for healthcare industry stakeholders. COVID-19 has significantly altered traditional approaches. It has also accelerated change and further exposed challenges within our system. Durin...
Patient Support Programs and Rare Disease
February 26, 2021 19:08 - 11 minutes - 15.3 MBIn this episode of Avalere Health Essential Voice focused on disease education, experts from our Market Access practice discuss support programs designed for rare disease patients, caregivers, and providers, particularly in light of the continued impact of COVID-19 on the patient population.
Telehealth Barriers and Opportunities for Nutrition Care Arising from the COVID-19 Pandemic
February 25, 2021 15:21 - 19 minutes - 27.2 MBIn this episode of Avalere Health Essential Voice, we welcome nutrition experts to discuss the use of telehealth in providing nutrition care during the pandemic, as well as future barriers and opportunities in virtual care.
Smart Food Policy for Healthy Food Labeling: Leading With Taste, Not Healthiness, to Shift Consumption and Enjoyment of Healthy Foods
February 23, 2021 16:33 - 16 minutes - 22.2 MBIn this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on how food labeling affects consumption. This episode is based on findings from an article published on PubMed.gov: Smart Food Policy for Healthy Food Labeling: Leading With Taste, Not Healthiness, to Shift Consumption and Enjoyment of Healthy Foods
Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma
February 12, 2021 15:04 - 12 minutes - 17 MBIn this episode of Avalere Health Essential Voice, our experts discuss recent research focused on patients who received CAR T-cell therapy for large B-cell lymphoma (LBCL) using Medicare fee-for-service claims data.
Avalere 2021 Healthcare Industry Outlook: Clearing the Path
January 07, 2021 20:17 - 58 minutes - 79.9 MBOn January 7, 2021, Sarah Butler led 4 panel discussions exploring the key healthcare questions for the upcoming year and evidence-based strategies for life sciences companies, health plans, and providers to overcome potential access barriers and improve health outcomes. Download the 2021 Avalere Healthcare Industry Outlook document. The archived video of the webinar will be available soon. Key Topics Navigating the post-election policy landscape, including the COVID-19 pandemic, health...
Patient Health, Food Insecurity, and the Impact of Medically Tailored Meals
December 22, 2020 16:07 - 14 minutes - 20.4 MBIn this episode of Avalere Health Essential Voice, experts from nutrition service organizations discuss the growing importance of medically tailored meals (MTM) in addressing food insecurity and poor health for medically complex individuals.
COVID-19 Vaccine State Plans
December 18, 2020 16:29 - 15 minutes - 20.9 MBIn this episode of Get the Facts on COVID-19, Avalere vaccines experts discuss state distribution plans for existing and future COVID-19 vaccines.
Measuring Equity from the Start: Disparities in the Health Development of US Kindergarteners
December 15, 2020 17:59 - 14 minutes - 20.4 MBIn this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on disparities in the health development of young children.
What's Next for Telehealth?
December 10, 2020 16:59 - 16 minutes - 22 MBIn this episode of Start Your Day with Avalere, our experts discuss how telehealth has evolved during the pandemic and where they believe the sector is headed.
Most Favored Nation Model Stakeholder Considerations
December 07, 2020 17:39 - 12 minutes - 17.2 MBIn this episode of Start Your Day with Avalere, our policy experts discuss the Most Favored Nation (MFN) drug pricing model due to begin on January 1.
Social Determinants of Health – The Importance of Data, Part 2
December 01, 2020 16:00 - 9 minutes - 13.4 MBIn Part 2 of this episode focused on social determinants of health (SDOH), Avalere experts discuss how life sciences companies are recognizing the importance of SDOH data and its impact on intervention development.